Latest news with #Adairs
West Australian
11 hours ago
- Business
- West Australian
Adairs' full-year earnings weighed down by promotional blitz
Home furnishings chain Adairs says it is on track to deliver record sales in the 2025 financial year, but heavy discounting to achieve this had dented margins. In a mixed trading update which sent shares down 18.4 per cent to $2.10 just after midday on Monday, Adairs said full-year sales were forecast to hit between $614 million to $618m, up from last year's $594.4m. Underlying earnings are expected to hit between $53.5m to $57m, which is flat against the $57.6m recorded last year. But the company — also behind furniture brands Focus and Mocka — said elevated promotional activity aimed at driving sales and managing stocks, alongside the weaker Australian dollar, was 'adversely impacting gross margins'. While its flagship Adairs and Mocka businesses were expected to deliver significant earnings before interest and taxes growth on last year, it would be offset by a material decline in the Focus brand, where sales remain challenging despite higher promotional activity. 'Management is evolving the positioning and execution capability of the business alongside the national store roll-out program, which is expected to accelerate in FY26,' the company said. 'Under Adairs' new leadership, significant changes are being implemented across the business, designed to reset the foundations for long-term growth.' Adairs last September named former Country Road managing director Elle Roseby as its new chief executive less than two months after she departed the scandal-ridden fashion house. Adairs is set to release its full-year results on August 27.
Yahoo
5 days ago
- Business
- Yahoo
Adairs Unlocks $5M in Annual Savings with Manhattan SCALE
Leading Australian home furnishings and décor retailer, Adairs, transforms supply chain, bringing operations in-house with Manhattan SCALE SYDNEY, June 18, 2025 /PRNewswire/ -- Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce, has successfully supported Adairs in transitioning its supply chain operations in-house with Manhattan's dynamic warehouse management system (WMS) Manhattan SCALE. As part of a strategic shift, Adairs moved away from a third-party logistics (3PL) model to take full ownership of its supply chain, taking full responsibility for costs, efficiency, and customer experience. This transition required the rapid deployment of WMS, and following a comprehensive evaluation, Manhattan SCALE was selected for its flexibility, automation integration, and omnichannel capabilities. "Bringing our supply chain in-house was a major decision, driven by our desire for greater operational control and the ability to better serve our customers," explained Justin Dowling, General Manager of Supply Chain at Adairs. "We wanted an off-the-shelf, ready-to-go solution that could be implemented with minimal customisation, and Manhattan SCALE has provided the successful technology backbone for this transition, allowing us to streamline operations, improve inventory management, and scale effectively for peak demand." The implementation of Manhattan SCALE was completed in just 12 months, with the system going live in July 2024 and the transition has already driven significant improvements across Adairs' operations. The retailer has delivered an additional one million units to retail stores compared to the previous year, experienced a 24% increase in ecommerce order fulfilment, and processed 17% higher inbound volume. The move has also resulted in significant cost savings, with Adairs reporting $5 million in annual savings. The enhanced system capabilities have enabled the company to consolidate its distribution operations and optimise its logistics network. Now, all orders, whether from online channels, retail stores, or corporate customers, are fulfilled from a single distribution centre, improving stock availability and ensuring a more seamless supply chain operation. This three-way partnership ensured that the system was designed with real-world warehouse operations in mind and aligned with Adairs' strategic goals. "This was not just a technology project, it was a supply chain transformation," said Justin Dowling, General Manager Supply Chain, Adairs. "From day one, our teams worked in close partnership with Manhattan to develop a solution that would not only meet our immediate needs but also future proof our operations." By prioritising operational input, Adairs successfully minimised disruptions during go-live and ensured rapid adoption among its warehouse staff and the system's intuitive interface improved training efficiency, making it easier to scale labour for peak demand periods. "Retailers need a supply chain that can support rapid changes in customer expectations while driving operational efficiencies," said Raghav Sibal, Managing Director, ANZ, Manhattan Associates. "By implementing Manhattan SCALE, Adairs has taken a proactive approach to modernising its operations and creating a more agile, resilient supply chain. We're proud to have played a role in Adairs' transformation and look forward to supporting its continued growth." Receive up-to-date product, customer, and partner news directly from Manhattan Associates on LinkedIn ENDS About Manhattan Associates Manhattan Associates is a global technology leader in supply chain and omnichannel commerce. We unite information across the enterprise, converging front-end sales with back-end supply chain execution. Our software, platform technology and unmatched experience help drive both top-line growth and bottom-line profitability for our customers. Manhattan Associates designs, builds and delivers leading edge cloud and on-premises solutions so that across the store, through your network or from your fulfilment centre, you are ready to reap the rewards of the omnichannel marketplace. For more information, please visit View original content to download multimedia: SOURCE Manhattan Associates Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
7NEWS
10-06-2025
- Lifestyle
- 7NEWS
Furniture Frenzy: The best EOFY deals to upgrade your home for half the price
There's something oddly satisfying about snagging a bargain right before the end of the financial year. Maybe it's the thrill of ticking off a long-awaited purchase, or simply knowing your timing was spot on. Either way, with EOFY sales popping up everywhere, now's the time to finally make that big-ticket buy you've been putting off. Whether you've been eyeing off a plush new lounge to level up your living room or you're dreaming of a bedframe that actually supports your mattress and your sense of style, there are plenty of solid options out there right now. You don't have to trawl through every site or second-guess whether you're getting bang for your buc k; we've done the hard work for you. From minimalist frames to sofa sets you'll never want to leave, we've rounded up some of the best deals worth snapping up while stock lasts. So go on, treat yourself to that upgrade you've been thinking about for months, your future self (and your back) will thank you. 1. Haven California Ivory Chaise Sofa 3 Seater, was $3399, now $1999 at James Lane If you've been holding out for a sofa that's both incredibly stylish and ridiculously comfortable, this is your moment. The Haven Chaise Sofa blends a clean, modern look with mid-century flair and generous proportions made for lounging. The ivory shade adds a bright, airy touch to any space, while the tailored details and plush cushions make it feel designer without the price tag. It's also customisable, make sure to choose the chaise side that works best for your living room layout. 2. BOWRAL Dining Table was $2499, now $1869 at Freedom This is not your average dining table. Made from rough-sawn Tasmanian oak, the BOWRAL is all about character, think gum veins, burls and a rugged timber finish that brings warmth and authenticity to any dining room. The angled post legs add a modern twist, and there's matching bench seating if you want to complete the set. With room to seat up to 10 people, it's made for long lunches, Sunday roasts and everything in between. 3. Adairs Sydney Dove Full Queen Bed was $1999.99, now $949.99 at Adairs Looking to give your bedroom a glow-up? The Sydney Bed in Dove from Adairs has major main-character energy. The full upholstered design feels luxe and inviting, while the neutral tone brings a calming palette that pairs with just about anything. You're saving over $1,000. Add the matching Sydney chair if you want to go all in on the makeover. 4. Pomaire 3 Legged Boucle Occasional Chair was $299.99, now $249.99 at Temple & Webster Every room needs that one piece that sparks joy, and this Pomaire chair is it. With a playful three-legged design and a soft, boucle-covered finish, it adds instant personality to your space. Use it as an accent in your lounge or as a reading nook chair in the bedroom; either way, it makes a strong (and very cute) design statement. 5. Cacnea Rattan Coffee Table with Glass Table Top was $419, now $305.10 at Luxo Living Equal parts boho and polished, this rattan and glass combo is a total scene-stealer. The Cacnea coffee table features a rounded silhouette that softens your space and layers in texture. It fits beautifully in coastal, classic or even contemporary settings thanks to the mix of natural rattan and sleek glass. Perfect for elevating your living room without overwhelming it. There's no better excuse to refresh your space than a juicy EOFY discount. Whether you're styling a new home, doing a long overdue upgrade or just feeling inspired to redecorate, now's your chance to score pieces that combine high design with high savings.
Yahoo
05-06-2025
- Business
- Yahoo
ASX Insights Adairs And 2 Other Promising Penny Stocks
The Australian stock market recently flirted with record highs, only to experience a sell-off that left it closing near its opening levels, highlighting the ongoing volatility across various sectors. In such fluctuating conditions, investors often look beyond the established giants to smaller companies that offer potential growth at a lower entry cost. While 'penny stocks' might sound like an outdated term, they continue to represent opportunities for those seeking affordable investments with promising financial foundations; in this article, we explore three such stocks on the ASX that demonstrate both resilience and potential. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.525 A$71.94M ★★★★★★ GTN (ASX:GTN) A$0.63 A$120.24M ★★★★★★ IVE Group (ASX:IGL) A$2.54 A$391.62M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.715 A$453.46M ★★★★★★ Tasmea (ASX:TEA) A$3.06 A$716.16M ★★★★★☆ Regal Partners (ASX:RPL) A$2.27 A$763.09M ★★★★★★ Accent Group (ASX:AX1) A$1.875 A$1.13B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.715 A$226.78M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.49 A$165.6M ★★★★★★ CTI Logistics (ASX:CLX) A$1.845 A$148.6M ★★★★☆☆ Click here to see the full list of 1,002 stocks from our ASX Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Adairs Limited is a specialty retailer offering home furnishings, furniture, and decoration products across Australia and New Zealand, with a market cap of A$484.27 million. Operations: The company's revenue is derived from three segments: Focus generating A$125.34 million, Mocka contributing A$53.57 million, and Adairs providing A$423.56 million. Market Cap: A$484.27M Adairs Limited, with a market cap of A$484.27 million, displays mixed financial health as a penny stock option. The company shows potential for earnings growth at 15.97% per year but has faced declining profits over the past five years. Its debt is well covered by operating cash flow and interest payments are manageable, indicating sound financial management despite short-term asset coverage issues for liabilities. Adairs trades below its estimated fair value and offers high-quality earnings; however, it faces challenges with an inexperienced board and management team alongside unstable dividend history and low return on equity at 13.9%. Click here and access our complete financial health analysis report to understand the dynamics of Adairs. Examine Adairs' earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Amcil Limited is a publicly owned investment manager with a market cap of A$347.08 million. Operations: The company's revenue is derived entirely from its investments, totaling A$9.74 million. Market Cap: A$347.08M AMCIL, with a market cap of A$347.08 million, presents a complex picture for penny stock investors. Despite high-quality earnings and an experienced management team averaging 8.9 years in tenure, the company struggles with negative earnings growth over the past year and low return on equity at 1.9%. While AMCIL is debt-free, which eliminates concerns about interest coverage or cash flow obligations related to debt, its short-term assets (A$12.3M) fall short of covering long-term liabilities (A$49.8M). Additionally, its dividend yield of 3.64% is not well-supported by earnings or free cash flows. Navigate through the intricacies of AMCIL with our comprehensive balance sheet health report here. Gain insights into AMCIL's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: ImpediMed Limited is a medical technology company that manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices in the United States and Europe, with a market cap of A$68.87 million. Operations: The company generates revenue of A$11.54 million from its medical technology segment. Market Cap: A$68.87M ImpediMed Limited, with a market cap of A$68.87 million, offers potential for penny stock investors due to its debt-free status and forecasted revenue growth of 51.06% annually. While the company has reduced losses over the past five years, it remains unprofitable with less than a year of cash runway based on current free cash flow trends. The management and board are relatively inexperienced, averaging under two years in tenure. Recent events include presentations at significant medical conferences and its removal from major indices like the S&P/ASX All Ordinaries Index, highlighting both opportunities and challenges ahead. Take a closer look at ImpediMed's potential here in our financial health report. Explore ImpediMed's analyst forecasts in our growth report. Jump into our full catalog of 1,002 ASX Penny Stocks here. Curious About Other Options? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ADH ASX:AMH and ASX:IPD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-05-2025
- Business
- Yahoo
Why Adairs Limited (ASX:ADH) Could Be Worth Watching
Adairs Limited (ASX:ADH), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the ASX over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, what if the stock is still a bargain? Today we will analyse the most recent data on Adairs's outlook and valuation to see if the opportunity still exists. Our free stock report includes 1 warning sign investors should be aware of before investing in Adairs. Read for free now. Great news for investors – Adairs is still trading at a fairly cheap price according to our price multiple model, where we compare the company's price-to-earnings ratio to the industry average. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 14.44x is currently well-below the industry average of 20.53x, meaning that it is trading at a cheaper price relative to its peers. However, given that Adairs's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. Check out our latest analysis for Adairs Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Adairs' earnings over the next few years are expected to increase by 64%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since ADH is currently below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple. Are you a potential investor? If you've been keeping an eye on ADH for a while, now might be the time to enter the stock. Its prosperous future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy ADH. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. You'd be interested to know, that we found 1 warning sign for Adairs and you'll want to know about it. If you are no longer interested in Adairs, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
